Polar Asset Management Partners Inc. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Polar Asset Management Partners Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2023$1,288,800
+0.6%
120,0000.0%0.02%
+21.1%
Q1 2023$1,281,600
-79.2%
120,000
-80.0%
0.02%
-75.0%
Q4 2022$6,157,226
+1.7%
599,9990.0%0.08%
+4.1%
Q3 2022$6,054,000
+0.7%
599,9990.0%0.07%
+4.3%
Q2 2022$6,012,000
+0.1%
599,9990.0%0.07%
+9.4%
Q1 2022$6,003,000
+1.0%
599,9990.0%0.06%
+1.6%
Q4 2021$5,946,000599,9990.06%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Beryl Capital Management LLC 542,376$5,570,3642.24%
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,287,5001.00%
Lynwood Capital Management Inc. 59,615$6130.74%
Sage Rock Capital Management LP 183,998$1,889,7150.59%
HGC Investment Management Inc. 1,000,000$10,1800.44%
GRITSTONE ASSET MANAGEMENT LLC 34,026$349,4570.44%
MMCAP International Inc. SPC 370,000$3,796,2000.38%
METEORA CAPITAL, LLC 168,532$1,730,8740.37%
Exos TFP Holdings LLC 125,771$1,290,4100.36%
Bulldog Investors, LLP 90,650$931,4290.28%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders